Literature DB >> 27933411

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.

Kelly K Hunt1, David M Euhus2, Judy C Boughey3, Anees B Chagpar4, Sheldon M Feldman5, Nora M Hansen6, Swati A Kulkarni6, David R McCready7, Eleftherios P Mamounas8, Lee G Wilke9, Kimberly J Van Zee10, Monica Morrow10.   

Abstract

Over the past several years, there has been an increasing rate of bilateral prophylactic mastectomy (BPM) and contralateral prophylactic mastectomy (CPM) surgeries. Since publication of the 2007 SSO position statement on the use of risk-reducing mastectomy, there have been significant advances in the understanding of breast cancer biology and treatment. The purpose of this manuscript is to review the current literature as a resource to facilitate a shared and informed decision-making process regarding the use of risk-reducing mastectomy.

Entities:  

Mesh：

Year:  2016        PMID： 27933411     DOI： 10.1245/s10434-016-5688-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


  21 in total

1.  Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Authors:  Thomas A D'Agostino; Abenaa M Brewster; Susan K Peterson; Isabelle Bedrosian; Patricia A Parker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

Review 2.  Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.

Authors:  Giacomo Montagna; Monica Morrow
Journal:  Expert Rev Anticancer Ther       Date:  2020-02-28       Impact factor: 4.512

3.  Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.

Authors:  Allison H West; Kathleen R Blazer; Jessica Stoll; Matthew Jones; Caroline M Weipert; Sarah M Nielsen; Sonia S Kupfer; Jeffrey N Weitzel; Olufunmilayo I Olopade
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

4.  Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.

Authors:  Nicole Christian; Emily C Zabor; Michael Cassidy; Jessica Flynn; Monica Morrow; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2019-11-15       Impact factor: 5.344

5.  Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer.

Authors:  David W Lim; Helene Retrouvey; Isabel Kerrebijn; Kate Butler; Anne C O'Neill; Tulin D Cil; Toni Zhong; Stefan O P Hofer; David R McCready; Kelly A Metcalfe
Journal:  Ann Surg Oncol       Date:  2021-04-05       Impact factor: 5.344

6.  The relationship between contralateral prophylactic mastectomy and breast reconstruction, complications, breast-related procedures, and costs: A population-based study of health insurance data.

Authors:  Mary C Schroeder; Yu-Yu Tien; Lillian M Erdahl; Ingrid M Lizarraga; Brahmendra R Viyyuri; Sonia L Sugg
Journal:  Surgery       Date:  2020-08-18       Impact factor: 3.982

7.  Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy.

Authors:  Shenin A Dettwyler; Darcy L Thull; Priscilla F McAuliffe; Jennifer G Steiman; Ronald R Johnson; Emilia J Diego; Phuong L Mai
Journal:  Breast Cancer Res Treat       Date:  2022-05-21       Impact factor: 4.872

8.  Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study.

Authors:  L Findlay-Shirras; I Lima; G Smith; M Clemons; A Arnaout
Journal:  Breast Cancer Res Treat       Date:  2020-10-30       Impact factor: 4.872

9.  Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.

Authors:  Ingrid M Lizarraga; Mary C Schroeder; Ismail Jatoi; Sonia L Sugg; Amy Trentham-Dietz; Laurel Hoeth; Elizabeth A Chrischilles
Journal:  Ann Surg Oncol       Date:  2021-07-12       Impact factor: 5.344

10.  The risk of contralateral breast cancer: a SEER-based analysis.

Authors:  Vasily Giannakeas; David W Lim; Steven A Narod
Journal:  Br J Cancer       Date:  2021-05-26       Impact factor: 9.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.